Greenwood : In Drug Pricing Debate, Politicians and Patients Are Not Talking About Same Price

BIO CEO Jim Greenwood gave the following keynote address at the BIO 2019 International Convention today in Philadelphia, highlighting how politicians and patients are talking about different things when discussing drug costs in the United States and why represents a threat to transformative breakthroughs currently in the development pipeline.